These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 15958188)

  • 1. The removal of pyroglutamic acid from monoclonal antibodies without denaturation of the protein chains.
    Werner WE; Wu S; Mulkerrin M
    Anal Biochem; 2005 Jul; 342(1):120-5. PubMed ID: 15958188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unfolding of the immunoglobulin light and heavy chains is required for the enzymatic removal of N-terminal pyroglutamyl residues.
    Hellström JL; Vehniäinen M; Mustonen M; Lövgren T; Lamminmäki U; Hellman J
    Biochim Biophys Acta; 2006 Nov; 1764(11):1735-40. PubMed ID: 17049319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-yield deblocking of amino termini of recombinant immunoglobulins with pyroglutamate aminopeptidase.
    Mozdzanowski J; Bongers J; Anumula K
    Anal Biochem; 1998 Jul; 260(2):183-7. PubMed ID: 9657876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deblocking of proteins containing N-terminal pyroglutamic acid.
    Mozdzanowski J
    Methods Mol Biol; 2003; 211():365-9. PubMed ID: 12489444
    [No Abstract]   [Full Text] [Related]  

  • 5. The use of FAB mass spectrometry and pyroglutamate aminopeptidase digestion for the structure determination of pyroglutamate in modified peptides.
    Kim J; Kim K
    Biochem Mol Biol Int; 1995 Apr; 35(4):803-11. PubMed ID: 7627130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Occurrence of the free and Peptide forms of pyroglutamic acid in plasma from the portal blood of rats that had ingested a wheat gluten hydrolysate containing pyroglutamyl peptides.
    Higaki-Sato N; Sato K; Inoue N; Nawa Y; Kido Y; Nakabou Y; Hashimoto K; Nakamura Y; Ohtsuki K
    J Agric Food Chem; 2006 Sep; 54(19):6984-8. PubMed ID: 16968052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of N-terminal glutamate cyclization of recombinant monoclonal antibody in formulation development.
    Yu L; Vizel A; Huff MB; Young M; Remmele RL; He B
    J Pharm Biomed Anal; 2006 Oct; 42(4):455-63. PubMed ID: 16828250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aminopeptidases: aminopeptidase M (EC 3.4.11.2), pyroglutamate aminopeptidase (EC 3.4.19.3), and prolidase (EC 3.4.13.9).
    Sweeney PJ; Walker JM
    Methods Mol Biol; 1993; 16():319-29. PubMed ID: 19082982
    [No Abstract]   [Full Text] [Related]  

  • 9. Formation of pyroglutamic acid from N-terminal glutamic acid in immunoglobulin gamma antibodies.
    Chelius D; Jing K; Lueras A; Rehder DS; Dillon TM; Vizel A; Rajan RS; Li T; Treuheit MJ; Bondarenko PV
    Anal Chem; 2006 Apr; 78(7):2370-6. PubMed ID: 16579622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative analysis of pyroglutamic acid in peptides.
    Suzuki Y; Motoi H; Sato K
    J Agric Food Chem; 1999 Aug; 47(8):3248-51. PubMed ID: 10552639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-terminal glutamate to pyroglutamate conversion in vivo for human IgG2 antibodies.
    Liu YD; Goetze AM; Bass RB; Flynn GC
    J Biol Chem; 2011 Apr; 286(13):11211-7. PubMed ID: 21282104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation and identification of indigestible pyroglutamyl peptides in an enzymatic hydrolysate of wheat gluten prepared on an industrial scale.
    Higaki-Sato N; Sato K; Esumi Y; Okumura T; Yoshikawa H; Tanaka-Kuwajima C; Kurata A; Kotaru M; Kawabata M; Nakamura Y; Ohtsuki K
    J Agric Food Chem; 2003 Jan; 51(1):8-13. PubMed ID: 12502378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A technique for the removal of pyroglutamic acid from the amino terminus of proteins using calf liver pyroglutamate amino peptidase.
    Podell DN; Abraham GN
    Biochem Biophys Res Commun; 1978 Mar; 81(1):176-85. PubMed ID: 26343
    [No Abstract]   [Full Text] [Related]  

  • 14. Method to convert N-terminal glutamine to pyroglutamate for characterization of recombinant monoclonal antibodies.
    Xu W; Peng Y; Wang F; Paporello B; Richardson D; Liu H
    Anal Biochem; 2013 May; 436(1):10-2. PubMed ID: 23357233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stability of thermostable alkaline protease from Bacillus licheniformis RP1 in commercial solid laundry detergent formulations.
    Sellami-Kamoun A; Haddar A; Ali Nel-H; Ghorbel-Frikha B; Kanoun S; Nasri M
    Microbiol Res; 2008; 163(3):299-306. PubMed ID: 16872818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A thermodynamic analysis of the binding interaction between polysorbate 20 and 80 with human serum albumins and immunoglobulins: a contribution to understand colloidal protein stabilisation.
    Garidel P; Hoffmann C; Blume A
    Biophys Chem; 2009 Jul; 143(1-2):70-8. PubMed ID: 19427732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Removal of N-terminal blocking groups from proteins.
    Fowler E; Moyer M; Krishna RG; Chin CC; Wold F
    Curr Protoc Protein Sci; 2001 May; Chapter 11():Unit 11.7. PubMed ID: 18429106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Removal of N-terminal blocking groups from proteins.
    Leone JW; Hampton B; Fowler E; Moyer M; Krishna RG; Chin CCQ
    Curr Protoc Protein Sci; 2011 Feb; Chapter 11():11.7.1-11.7.20. PubMed ID: 21400688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression, physicochemical characterization, and modeling of a hyperthermophilic pyrococcus furiosus type 2 IPP isomerase.
    Dutoit R; de Ruyck J; Durisotti V; Legrain C; Jacobs E; Wouters J
    Proteins; 2008 Jun; 71(4):1699-707. PubMed ID: 18076031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Truncated prolyl oligopeptidase from Pyrococcus furiosus.
    Juhász T; Szeltner Z; Polgár L
    Proteins; 2007 Nov; 69(3):633-43. PubMed ID: 17623862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.